ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "pregnancy"

  • Abstract Number: 1395 • ACR Convergence 2020

    Poor Maternal and Fetal Outcome in Indian Women with Systemic Sclerosis: Interview-based Study at a Tertiary Center in India

    Rajat Kharbanda1, Naveen R2, Durga P Misra2, Latika Gupta3 and Vikas Agarwal4, 1SGPGIMS, Lucknow, Lucknow, Uttar Pradesh, India, 2Sanjay Gandhi Post graduate institute of medical sciences, Lucknow, Uttar Pradesh, India, 3Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 4Sanjay Gandhi Post Graduate Institute of Medical Sciences, LUCKNOW, India

    Background/Purpose: Poor obstetric outcomes have been described in Systemic sclerosis (SSc) in the developed world. We assessed effect of the disease in Indian women and…
  • Abstract Number: 1774 • ACR Convergence 2020

    Making Decisions About Medication Use, Pregnancy, and Having Children Among Women with Rheumatoid Arthritis: A Constructivist Grounded Theory Study

    Nevena Rebic1, Ria Garg2, Sarah Munro2, Glen Hazlewood3, Neda Amiri2, Nick Bansback2, Stephanie Ensworth2, Corisande Baldwin4, Laurie Proulx5 and Mary De Vera1, 1Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3University of Calgary, Calgary, AB, Canada, 4University of British Columbia, Calgary, AB, Canada, 5Canadian Arthritis Patient Alliance, Ottawa, Canada

    Background/Purpose: Despite guidelines for managing rheumatoid arthritis (RA) in pregnancy, high rates of discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) considered safe for women with RA…
  • Abstract Number: 1446 • ACR Convergence 2020

    Pregnancy Outcomes in Patients with Interstitial Lung Disease

    Aardra Rajendran1, Stephanie Giattino2, Amanda Eudy3, Aparna Swaminathan4 and Megan Clowse5, 1Duke University, Lewisville, NC, 2Duke University, Media, PA, 3Duke University, Durham, NC, 4Duke University, Durham, 5Duke University, Chapel Hill, NC

    Background/Purpose: Patients with interstitial lung disease (ILD) are often recommended to avoid conception or terminate pregnancy despite limited data on pregnancy outcomes and complications. Studies…
  • Abstract Number: 1775 • ACR Convergence 2020

    Risk Factors for Adverse Pregnancy Outcomes of Women with Positive for Antiphospholipid Antibodies Treated with Conventional Therapies

    Hiromi Shimada1, Risa Wakiya2, Mai Mahmound Fahmy Mansour1, Shusaku Nakashima1, Mikiya Kato1, Koichi Sugihara1, Yusuke Ushio1, Tomohiro Kameda1 and Hiroaki Dobashi3, 1Department of Internal Medicine, Division of Haematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University., Kita-gun, Kagawa, Japan, 2Department of Internal Medicine, Division of Haematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University., Kagawa, Kagawa, Japan, 3Department of Internal Medicine, Division of Haematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan

    Background/Purpose: Antiphospholipid antibodies induce several obstetric complications including recurrent spontaneous abortion, preterm birth, intrauterine fetal death. EULAR recommendations for antiphospholipid syndrome (APS) indicates low dose…
  • Abstract Number: 0033 • ACR Convergence 2020

    Pre-pregnancy Long Non-coding RNA Expression Signatures Among Women with Rheumatoid Arthritis Who Improve or Worsen During Pregnancy

    Matthew Wright1, Mette Kiel Smed2, J Lee Nelson3, Jørn Olsen4, Merete Hetland5, Vibeke Zoffmann2 and Damini Jawaheer6, 1UCSF Children's Hospital Oakland Research Institute, Oakland, CA, 2The Juliane Marie Center, Copenhagen, Denmark, 3Fred Hutchinson Cancer Res Ctr and U of WA, Seattle, WA, 4Aarhus University Hospital, Aarhus, Denmark, 5The DANBIO Registry, Rigshospitalet, Glostrup, Denmark, 6UCSF Benioff Children's Hospital Oakland Research Institute, Oakland, CA

    Background/Purpose: Pregnancy is known to have disease-modifying effects on rheumatoid arthritis (RA). A role for long non-coding (lnc) RNAs in the improvement or worsening of…
  • Abstract Number: 1497 • ACR Convergence 2020

    COVID-19 in Pregnant Patients with Rheumatic Disease: Data from the COVID-19 Global Rheumatology Alliance

    Bonnie Bermas1, Megan Clowse2, Milena Gianfrancesco3, Jonathan Hausmann4, Pedro M Machado5, Emily Sirotich6, Helen Robinson7, Anja Strangfeld8, Jinoos Yazdany9 and Philip Robinson10, 1UTSouthwestern.edu, Dallas, TX, 2Duke University, Chapel Hill, NC, 3University of California, San Francisco, San Francisco, CA, 4Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA, 5University College London, London, United Kingdom, 6McMaster University, Hamilton, ON, Canada, 7University of Queensland School of Medicine, HERSTON, Queensland, Australia, 8German Rheumatism Research Center, Berlin, Germany, 9UCSF, San Francisco, CA, 10University of Queensland, Herston, Queensland, Australia

    Background/Purpose: The impact of COVID-19 on pregnancy in patients with rheumatic disease is unknown. We describe COVID-19 outcomes in pregnant rheumatic disease patients reported to…
  • Abstract Number: 1776 • ACR Convergence 2020

    Safety and Beneficial Effects of Hydroxychloroquine on Pregnancy Outcomes in Women with Systemic Lupus Erythematosus

    Isabell Haase1, Matthias Schneider1, Ralph Brinks1 and Rebecca Fischer-Betz1, 1Department of Rheumatology and Hiller Research Unit Rheumatology, Heinrich Heine University, Duesseldorf, Germany, Duesseldorf, Germany

    Background/Purpose: The use of hydroxychloroquine (HCQ) has long been established in Systemic Lupus Erythematosus(SLE) and especially as applicable drug during pregnancy. Recently, beneficial effects and…
  • Abstract Number: 0238 • ACR Convergence 2020

    Gestational Desire and Certolizumab Pegol in Patients with Chronic Inflammatory Rheumatic Disease. Preliminary Results of the GESTAMAD Cohort

    Laura Gonzalez Hombrado1, Marina Salido Olivares2, Maria Carmen Ortega de la O3, Pilar Navarro Alonso4, Patricia Castro Perez5, Ana Castilla6, Alvaro Garcia Martos7, Celia Arconada3, Angel Aragon Diez8, Carolina Marin huertas3 and Eva Maria Andres Esteban9, 1Hospital Universitario del Tajo, MADRID, Spain, 2Hospital de Parla, Madrid, Spain, 3Hospital infanta Elena, Madrid, Spain, 4Hospital de Fuenlabrada, Madrid, Madrid, Spain, 5Hospital Universitario de Getafe, Madrid, Spain, 6Hospital Universitario La Paz, Madrid, Spain, 7Hospital Universitario del Tajo, Madrid, 8Hospital Universitario de Gerafe, Madrid, Spain, 9Rey Juan Carlos University, Madrid, Spain

    Background/Purpose: INTRODUCTION The use of biological therapies during pregnancy has been contraindicated since the beginning of the use of these drugs. In recent years several…
  • Abstract Number: 1498 • ACR Convergence 2020

    Pregnancy Outcomes in Patients with Axial Spondyloarthritis – a First Analysis of a European Collaboration of Pregnancy Registries

    Yvette Meissner1, Nathalie Costedoat-Chalumeau2, Frauke Foerger3, Doreen Goll4, Anna Molto5, Rebecca Özdemir6, Marianne Wallenius7, Anja Strangfeld8 and Rebecca Fischer-Betz9, 1Deutsches Rheuma-Forschungszentrum, Berlin, Germany, 2APHP, Université de Paris, Paris, France, 3University Hospital and University of Bern, Bern, Switzerland, Bern, Switzerland, 4Patient Research Partner, Berlin, Germany, 5Rheumatology Department, Cochin Hospital, Paris, Paris, France, 6Patient Research Partner, Duisburg, Germany, 7University Hospital and Norwegian University of Science and Technology, Trondheim, Norway, 8German Rheumatism Research Center, Berlin, Germany, 9Department of Rheumatology and Hiller Research Unit Rheumatology, Heinrich Heine University, Duesseldorf, Germany, Duesseldorf, Germany

    Background/Purpose: Axial spondyloarthritis (axSpA) can affect women in their childbearing age. Data on pregnancy in axSpA patients are mainly retrospective and highly heterogeneous [1]. The…
  • Abstract Number: 1777 • ACR Convergence 2020

    Low Dose Aspirin to Prevent Pre-eclampsia in SLE Pregnancies – Counselling Helps to Realize Our Full Potential

    Isabell Haase1, Matthias Schneider1, Ralph Brinks1 and Rebecca Fischer-Betz1, 1Department of Rheumatology and Hiller Research Unit Rheumatology, Heinrich Heine University, Duesseldorf, Germany, Duesseldorf, Germany

    Background/Purpose: Women with Systemic Lupus Erythematosus (SLE) face a higher risk of pre-eclampsia, especially those with additional risk factors. Low dose aspirin (LDA) is known…
  • Abstract Number: 0247 • ACR Convergence 2020

    Lupus Low Disease Activity State Achievement Is Important for Reducing Adverse Outcomes in Pregnant Patients with Systemic Lupus Erythematosus

    Ji-Won Kim1, Ju-Yang Jung1, Hyoun-Ah Kim1 and Chang-Hee Suh1, 1Ajou university school of medicine, Suwon, Republic of Korea

    Background/Purpose: This study aimed to examine the frequency and risk factors of complications during pregnancy in women with systemic lupus erythematosus (SLE).Methods: The medical records…
  • Abstract Number: 1500 • ACR Convergence 2020

    Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation

    Deborah Friedman1, Mimi Kim2, Nathalie Costedoat-Chalumeau3, Robert Clancy4, Joshua Copel5, Colin Phoon6, Bettina Cuneo7, Rebecca Cohen6, Mala Masson6, Benjamin Wainwright6, Noel Zahr8, Amit Saxena4, Peter Izmirly9 and Jill Buyon10, 1New York Medical College, Valhalla, 2Albert Einstein College of Medicine, Bronx, 3APHP, Université de Paris, Paris, France, 4NYU School of Medicine, New York, 5Yale School of Medicine, New Haven, 6New York University School of Medicine, New York, 7University of Colorado School of Medicine, Aurora, 8Pitié-Salpêtrière University Hospital, Paris, France, 9Department of Medicine, New York University School of Medicine, New York, NY, 10Department of Medicine, NYU School of Medicine, New York, NY

    Background/Purpose: Based on inhibition of viral replication and limited reports on clinical efficacy, hydroxychloroquine (HCQ) was initially considered as a prophylaxis and treatment of COVID-19. …
  • Abstract Number: 1780 • ACR Convergence 2020

    Maternal and Fetal Outcomes in Pregnant Women with Psoriatic Arthritis: A Systematic Literature Review

    Agna Neto1, Rita Pinheiro Torres2, Helena Donato3, Ana Filipa Mourão2, Jaime Branco2 and Fernando Pimentel-Santos4, 11. Rheumatology Department, Hospital Central do Funchal, Madeira, Portugal. 2. Hospital de Egas Moniz, CHLO, Lisbon, Portugal. 3. CEDOC, NOVA Medical School, Lisbon, Portugal, Lisbon, Portugal, 22. Hospital de Egas Moniz, CHLO, Lisbon, Portugal. 3. CEDOC, NOVA Medical School, Lisbon, Portugal, Lisbon, Portugal, 34. Serviço de Documentação, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, Coimbra, Portugal, 43.CEDOC, NOVA Medical School, Faculdade de Ciências Médicas da Universidade NOVA de Lisboa, Lisboa, Portugal; 7.Hospital Egas Moniz (CHLO) (Rheumatology Department), Lisboa, Portugal, Lisbon, Portugal

    Background/Purpose: The onset of psoriatic arthritis (PsA) often occurs between the ages of 30 and 50 years. Accordingly, many female patients are diagnosed during childbearing…
  • Abstract Number: 0262 • ACR Convergence 2020

    SLE Pregnancies: C4 as Predictor of Flares and Adverse Pregnancy Outcomes

    Francesca Crisafulli1, Laura Andreoli1, Matteo Filippini1, Micaela Fredi1, Maria Chiara Gerardi1, Roberto Gorla2, Maria Grazia Lazzaroni1, Daniele Lini1, Cecilia Nalli2, Marco Taglietti1, Andrea Lojacono3, Sonia Zatti3, Cristina Zanardini3, Franco Franceschini1 and Angela Tincani1, 1Rheumatology and Clinical Immunology Unit, Spedali Civili and University of Brescia, Brescia, Lombardia, Italy, 2Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Lombardia, Italy, 3Obstetrics and Gynecology Unit, Spedali Civili and University of Brescia, Brescia, Lombardia, Italy

    Background/Purpose: SLE pregnancies have an increased risk of Adverse Pregnancy Outcomes (APO). In clinical practice, low C3 and C4 levels are associated with active disease…
  • Abstract Number: 1501 • ACR Convergence 2020

    Obstetrical Outcome and Thromboses in a Multicentric Cohort of Antiphospholipid Syndrome (APS) Patients with Severe Preeclampsia: An Analysis of APS Classification Criteria

    Maddalena Larosa1, Nathalie Morel2, Meriem Belhocine3, Amelia Ruffatti4, Nicolas Martin Silva5, Romain Paule6, Luc Mouthon7, Michel Dreyfus8, Jean-Charles Piette9, Odile Souchaud-Debouverie10, Catherine Deneux-Tharaux11, Vassilis Tsatsaris12, Emmanuelle Pannier Metzger13, Gaëlle Guettrot-Imbert14, Veronique Le Guern15, Andrea Doria16 and Nathalie Costedoat-Chalumeau17, 1Rheumatology Unit-Department of Medicine-University of Padova, Italy, Padova, Veneto, Italy, 2AP-HP, université René-Descartes Paris V, hôpital Cochin, centre de référence maladies auto-immunes et systémiques rares, pôle médecine, service de médecine interne, Paris, France., Paris, Ile-de-France, France, 3Hôpital Sacré-Coeur de Montréal , Montréal, Montreal, QC, Canada, 4Department of Medicine, University of Padova, Padova, Veneto, Italy, 5Centre Hospitalier et Universitaire de Caen, Caen, France, 6Foch Hospital, Paris, France, 7Hopital Cochin - Paris University, Paris, France, 8CHU de Caen, Caen, France, 9Department of Internal Medicine, Hôpital Pitié-Salpêtrière, Paris, France, Paris, France, 10CENTRE HOSPITALIER UNIVERSITAIRE LA MILETRIE, poitiers, France, 11INSERM U1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Center for Epidemiology and Statistics Sorbonne Paris Cité , Paris Descartes University , Paris , France, Paris, France, 12Maternité Port-Royal,Hôpital Cochin, Paris, France, Paris, France, 13Maternité Port-Royal,Hôpital Cochin, Paris, France, 14Médecine Interne,Hôpital Cochin, paris, France, 15Médecine Interne,Hôpital Cochin, Paris, France, Paris, France, 16University of Padua, Padua, Italy, 17APHP, Université de Paris, Paris, France

    Background/Purpose: According to APS classification criteria1, clinical manifestations of antiphospholipid syndrome (APS) consist in thrombotic and obstetric events, including severe preeclampsia (PE). Because little is…
  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.